Skip to main content
. Author manuscript; available in PMC: 2021 Aug 11.
Published in final edited form as: Nat Aging. 2021 Feb 11;1(2):205–217. doi: 10.1038/s43587-021-00027-5

Extended Data Fig. 3. TGF-β1 downregulates SIRT3 and FoxO3a levels in human fibroblasts.

Extended Data Fig. 3

Top panel, schematic diagram showing experiment design. Bottom panel, western blots demonstrating early and late downregulation of SIRT3 and FoxO3a, respectively, and upregulation of α-SMA at indicated time points in TGF-β1 treatment of human fibroblasts.